Author:
Fung John J.,Bradley J. Andrew
Reference35 articles.
1. Ponticelli C, Tarantino A, Segoloni G, et al. A randomised study comparing three cyclosporinbased regimens in cadaveric renal transplantation. J Am Soc Nephrol 1997;8:638–45.
2. Thiel G, Bock A, Spondlin M, et al. Long-term benefits and risks of cyclosporin-A (Sandimmun): an analysis at 10 years. Transplant Proc 1994;26:2493–8.
3. Szczech L, Berlin J, Aradhye S, et al. Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. J Am Soc Nephrol 1997;8:1771–7.
4. Szczech L, Berlin J, Feldman HI, et al. The effect of anti-lymphocyte induction therapy on renal allograft survival. Ann Intern Med 1998;128:817–26.
5. Katznelson S, Cecka J. Immunosuppressive regimens and their effects on renal allograft outcome. In: Cecka J, Terasaki P. Editors. Clinical Transplants Los Angeles, CA: UCLA Tissue Typing Laboratory, 1996;361–71.